KBC Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73K | Sell |
3,387
-1,312
| -28% | -$28.3K | ﹤0.01% | 1406 |
|
|
2025
Q1 | $114K | Hold |
4,699
| – | – | ﹤0.01% | 1407 |
|
|
2024
Q4 | $98K | Buy |
4,699
+1,542
| +49% | +$32.2K | ﹤0.01% | 1564 |
|
|
2024
Q3 | $63K | Hold |
3,157
| – | – | ﹤0.01% | 1593 |
|
|
2024
Q2 | $49K | Hold |
3,157
| – | – | ﹤0.01% | 1631 |
|
|
2024
Q1 | $50K | Hold |
3,157
| – | – | ﹤0.01% | 1557 |
|
|
2023
Q4 | $53K | Sell |
3,157
-518
| -14% | -$8.7K | ﹤0.01% | 1481 |
|
|
2023
Q3 | $43K | Sell |
3,675
-3,929
| -52% | -$46K | ﹤0.01% | 1561 |
|
|
2023
Q2 | $102K | Sell |
7,604
-625
| -8% | -$8.38K | ﹤0.01% | 1173 |
|
|
2023
Q1 | $136K | Hold |
8,229
| – | – | ﹤0.01% | 1098 |
|
|
2022
Q4 | $153K | Hold |
8,229
| – | – | ﹤0.01% | 1055 |
|
|
2022
Q3 | $106K | Buy |
+8,229
| New | +$106K | ﹤0.01% | 1160 |
|